65 -- Viroseq HIV-1 Genotype System

The Centers for Disease Control and Prevention (CDC) plans to issue a sole source purchase order valued at $34,128.00 to Abbott Molecular Inc. for acquiring six units each of the Viroseq HIV-1 V2 Genotype Systems and the Viroseq HIV-1 V2 Genotype. The CDC has determined that Abbott Molecular Inc. is uniquely qualified to fulfill the specific requirements of this order under FAR subpart 13.106-1(b). However, the CDC is open to receiving capabilities statements from other interested parties who believe they can provide the requested products. These statements will be evaluated solely to decide whether to initiate a competitive procurement process. Interested vendors must submit their documentation within 15 days from the publication date of the synopsis to be considered. Submissions should be sent to Ronnie Francis via fax or email as provided, and the decision on whether to proceed with competition rests entirely with the CDC. The solicitation reference for this procurement is 2007-Q-47827, and the related NAICS code is 325413, corresponding to pharmaceutical manufacturing. Points of contact for the contract include Ronnie E. Francis and Patrick W. Gourley, who can be reached via CDC email and phone.